Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
13F holders, Q2 2025
Institutional positions in Kezar Life Sciences, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −1 vs. Q1 2025
- Shares held
- 4.47M
- +146.6K (+3.4%) vs. Q1 2025
- Total value
- $20.5M
- −$627.1K (−3.0%) vs. Q1 2025
- New holders
- 3
- 11 more added
- Sold out
- 4
- 8 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 43 | $32.8M |
| Q4 2025 | 43 | $28.1M |
| Q3 2025 | 39 | $16.5M |
| Q2 2025 | 40 | $20.5M |
| Q1 2025 | 41 | $21.1M |
| Q4 2024 | 43 | $28.2M |
| Q3 2024 | 60 | $31.6M |
| Q2 2024 | 81 | $23.6M |
| Q1 2024 | 85 | $40.3M |
| Q4 2023 | 81 | $46.8M |
| Q3 2023 | 82 | $66.0M |
| Q2 2023 | 104 | $139.4M |
| Q1 2023 | 137 | $188.1M |
| Q4 2022 | 123 | $404.2M |
| Q3 2022 | 132 | $495.5M |
| Q2 2022 | 127 | $454.0M |
| Q1 2022 | 123 | $734.1M |
| Q4 2021 | 107 | $674.1M |
| Q3 2021 | 77 | $242.7M |
| Q2 2021 | 75 | $150.1M |
| Q1 2021 | 83 | $158.0M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Kezar Life Sciences, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 43 | $0 | 0.00% | +43 | New |
| Barclays PLC | 1 | $5 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 41 | $188 | 0.00% | −1,999−98.0% | Reduced |
| Citigroup Inc | 51 | $234 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 90 | $412 | 0.00% | +86+2,150.0% | Added |
| BNP Paribas Arbitrage, SA | 96 | $440 | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 100 | $458 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 145 | $664 | 0.00% | +145 | New |
| Bank of America Corp | 180 | $824 | 0.00% | +8+4.7% | Added |
| JPMorgan Chase & Co | 209 | $957 | 0.00% | +43+25.9% | Added |
| Global Retirement Partners, LLC | 1,000 | $4.58K | 0.00% | +1,000 | New |
| Wells Fargo & Company | 5,746 | $26.3K | 0.00% | +43+0.8% | Added |
| Morgan Stanley | 8,693 | $39.8K | 0.00% | +1,482+20.6% | Added |
| Northern Trust Corp | 13,940 | $63.8K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 20,900 | $95.7K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,093 | $96.6K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 22,665 | $103.8K | 0.00% | +8,360+58.4% | Added |
| Two Sigma Investments, LP | 24,883 | $114.0K | 0.00% | −6,987−21.9% | Reduced |
| Millennium Management LLC | 25,677 | $117.6K | 0.00% | −5,703−18.2% | Reduced |
| RBF Capital, LLC | 28,253 | $129.4K | 0.01% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 29,970 | $137.3K | 0.00% | −2,340−7.2% | Reduced |
| Bridgeway Capital Management, LLC | 41,000 | $187.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 54,641 | $250.3K | 0.00% | −9,868−15.3% | Reduced |
| Sphera Funds Management Ltd. | 58,539 | $268.1K | 0.07% | −49,934−46.0% | Reduced |
| Geode Capital Management, LLC | 65,119 | $298.3K | 0.00% | −2,445−3.6% | Reduced |
| Shay Capital LLC | 67,661 | $309.9K | 0.07% | +150+0.2% | Added |
| Qiming U.S. Ventures Management, LLC | 82,871 | $379.5K | 1.61% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 87,284 | $399.8K | 0.00% | +1,700+2.0% | Added |
| BlackRock, Inc. | 97,671 | $447.3K | 0.00% | +15,057+18.2% | Added |
| Ikarian Capital, LLC | 106,901 | $489.6K | 0.16% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 115,123 | $527.3K | 0.53% | −9,304−7.5% | Reduced |
| Acadian Asset Management LLC | 133,525 | $610.0K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 147,404 | $675.1K | 0.11% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 169,859 | $778.0K | 0.77% | +69,859+69.9% | Added |
| OrbiMed Advisors LLC | 192,700 | $882.6K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 276,228 | $1.27M | 0.00% | 00.0% | Unchanged |
| Avidity Partners Management LP | 502,600 | $2.30M | 0.46% | 00.0% | Unchanged |
| BML Capital Management, LLC | 635,183 | $2.91M | 2.23% | +227,045+55.6% | Added |
| Suvretta Capital Management, LLC | 716,759 | $3.28M | 0.12% | 00.0% | Unchanged |
| Tang Capital Management LLC | 720,000 | $3.30M | 0.17% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −28,178−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −25,555−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −20,299−100.0% | Sold out |
| Clear Harbor Asset Management, LLC | 0 | $0 | 0.00% | −15,805−100.0% | Sold out |